BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 18505904)

  • 1. Identification of a clinically homogenous subgroup of benign cortisol-secreting adrenocortical tumors characterized by alterations of the protein kinase A (PKA) subunits and high PKA activity.
    Vincent-Dejean C; Cazabat L; Groussin L; Perlemoine K; Fumey G; Tissier F; Bertagna X; Bertherat J
    Eur J Endocrinol; 2008 Jun; 158(6):829-39. PubMed ID: 18505904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different expression of protein kinase A (PKA) regulatory subunits in cortisol-secreting adrenocortical tumors: relationship with cell proliferation.
    Mantovani G; Lania AG; Bondioni S; Peverelli E; Pedroni C; Ferrero S; Pellegrini C; Vicentini L; Arnaldi G; Bosari S; Beck-Peccoz P; Spada A
    Exp Cell Res; 2008 Jan; 314(1):123-30. PubMed ID: 17904549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PKA catalytic subunit mutations in adrenocortical Cushing's adenoma impair association with the regulatory subunit.
    Calebiro D; Hannawacker A; Lyga S; Bathon K; Zabel U; Ronchi C; Beuschlein F; Reincke M; Lorenz K; Allolio B; Kisker C; Fassnacht M; Lohse MJ
    Nat Commun; 2014 Dec; 5():5680. PubMed ID: 25477193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.
    Bertherat J; Groussin L; Sandrini F; Matyakhina L; Bei T; Stergiopoulos S; Papageorgiou T; Bourdeau I; Kirschner LS; Vincent-Dejean C; Perlemoine K; Gicquel C; Bertagna X; Stratakis CA
    Cancer Res; 2003 Sep; 63(17):5308-19. PubMed ID: 14500362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of benign unilateral adrenocortical tumors: focus on cAMP/PKA pathway.
    Weigand I
    Minerva Endocrinol; 2019 Mar; 44(1):25-32. PubMed ID: 29963826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotropin-independent macronodular adrenal hyperplasia.
    Bourdeau I; Matyakhina L; Stergiopoulos SG; Sandrini F; Boikos S; Stratakis CA
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3626-32. PubMed ID: 16772351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
    Gaujoux S; Tissier F; Groussin L; Libé R; Ragazzon B; Launay P; Audebourg A; Dousset B; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4135-40. PubMed ID: 18647815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cAMP signaling in cortisol-producing adrenal adenoma.
    Calebiro D; Di Dalmazi G; Bathon K; Ronchi CL; Beuschlein F
    Eur J Endocrinol; 2015 Oct; 173(4):M99-106. PubMed ID: 26139209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase A alterations in adrenocortical tumors.
    Espiard S; Ragazzon B; Bertherat J
    Horm Metab Res; 2014 Nov; 46(12):869-75. PubMed ID: 25105543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroidogenic Acute Regulatory Protein Overexpression Correlates with Protein Kinase A Activation in Adrenocortical Adenoma.
    Zhou W; Wu L; Xie J; Su T; Jiang L; Jiang Y; Cao Y; Liu J; Ning G; Wang W
    PLoS One; 2016; 11(9):e0162606. PubMed ID: 27606678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 8Cl-cAMP modifies the balance between PKAR1 and PKAR2 and modulates the cell cycle, growth and apoptosis in human adrenocortical H295R cells.
    Bouizar Z; Ragazzon B; Viou L; Hortane M; Bertherat J; Rizk-Rabin M
    J Mol Endocrinol; 2010 Jun; 44(6):331-47. PubMed ID: 20237143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of the Carney complex gene 1 (protein kinase A regulatory subunit 1A) inhibits SMAD3 expression and TGF beta-stimulated apoptosis in adrenocortical cells.
    Ragazzon B; Cazabat L; Rizk-Rabin M; Assie G; Groussin L; Fierrard H; Perlemoine K; Martinez A; Bertherat J
    Cancer Res; 2009 Sep; 69(18):7278-84. PubMed ID: 19738044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase a regulatory subunit 1A protein.
    Lania AG; Mantovani G; Ferrero S; Pellegrini C; Bondioni S; Peverelli E; Braidotti P; Locatelli M; Zavanone ML; Ferrante E; Bosari S; Beck-Peccoz P; Spada A
    Cancer Res; 2004 Dec; 64(24):9193-8. PubMed ID: 15604292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of PRKAR1A and Gs(alpha) in sporadic adrenocortical tumors.
    Libé R; Mantovani G; Bondioni S; Lania AG; Pedroni C; Beck-Peccoz P; Spada A
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):248-51. PubMed ID: 15926108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of PRKAR1A and PRKAR2B depletion on signaling pathways, cell growth, and cell cycle control of adrenocortical cells.
    Basso F; Rocchetti F; Rodriguez S; Nesterova M; Cormier F; Stratakis CA; Ragazzon B; Bertherat J; Rizk-Rabin M
    Horm Metab Res; 2014 Nov; 46(12):883-8. PubMed ID: 25268545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase A alterations in endocrine tumors.
    Yu B; Ragazzon B; Rizk-Rabin M; Bertherat J
    Horm Metab Res; 2012 Sep; 44(10):741-8. PubMed ID: 22752956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRKAR1A Mutations and protein kinase A interactions with other signaling pathways in the adrenal cortex.
    Robinson-White A; Meoli E; Stergiopoulos S; Horvath A; Boikos S; Bossis I; Stratakis CA
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2380-8. PubMed ID: 16569736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of gene expression profiles associated with cortisol secretion in adrenocortical adenomas.
    Wilmot Roussel H; Vezzosi D; Rizk-Rabin M; Barreau O; Ragazzon B; René-Corail F; de Reynies A; Bertherat J; Assié G
    J Clin Endocrinol Metab; 2013 Jun; 98(6):E1109-21. PubMed ID: 23539725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activating mutations of GNAS in canine cortisol-secreting adrenocortical tumors.
    Kool MM; Galac S; Spandauw CG; Kooistra HS; Mol JA
    J Vet Intern Med; 2013; 27(6):1486-92. PubMed ID: 24112376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The computed tomography adrenal wash-out analysis properly classifies cortisol secreting adrenocortical adenomas.
    Humbert AL; Lecoanet G; Moog S; Bouderraoui F; Bresler L; Vignaud JM; Chevalier E; Brunaud L; Klein M; Cuny T
    Endocrine; 2018 Mar; 59(3):529-537. PubMed ID: 29332161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.